ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Brenner To Leave Breast Cancer Action

September 17, 2010

Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women

July 25, 1980

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

In Brief: Ruddon To Head Eppley Institute; Shapiro elected ACR President; ACR Medalists Named

November 3, 1989